• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎分子诊断的优势与局限性。

Strengths and limitations of molecular diagnostics for pneumonia.

机构信息

Institute of Infection and Immunity, St George's Hospital and St George's University, London, UK.

Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France.

出版信息

Expert Rev Mol Diagn. 2024 Oct;24(10):899-911. doi: 10.1080/14737159.2024.2405920. Epub 2024 Nov 18.

DOI:10.1080/14737159.2024.2405920
PMID:39552603
Abstract

INTRODUCTION

While pneumonia (PcP) remains a major AIDS-defining disease, the majority of cases of PcP now present in the HIV-negative cohort, causing significant mortality. PcP PCR diagnosis is not novel, and the optimal route of diagnosis remains unclear, with an imperfect reference method and complexity in result interpretation for alternative tests.

AREAS COVERED

This extensive review utilizing a literature search underpinning a recent systematic review/meta-analysis discusses the technical and clinical performance of PcP PCR, the added benefits of PCR testing, future aspects/considerations, and how PCR may be best used in clinical algorithms to provide a probability of PcP.

EXPERT OPINION

Given the current imperfect reference test for PcP, an alternative would be beneficial. Concerns over PcP PCR generating false positive results are valid but can be resolved by using positivity thresholds that drive specificity. Unfortunately, the extensive range of PCR assays complicates the provision of a PCR reference method. Combination testing incorporating PCR and B-D-Glucan, along with clinical and host risk factors, is key to understanding the individual probability of PcP. It is critical that access to PcP PCR testing is improved through technical and logistical development. Conversely, syndromic approaches including PcP need to be fully evaluated.

摘要

简介

虽然肺炎(PcP)仍然是艾滋病的主要定义性疾病,但现在大多数 PcP 病例出现在 HIV 阴性人群中,导致了显著的死亡率。PcP PCR 诊断并不新颖,最佳诊断途径仍不清楚,参考方法并不完善,替代检测的结果解释也很复杂。

涵盖领域

本综述广泛利用了一篇文献检索,为最近的系统综述/荟萃分析提供了支持,讨论了 PcP PCR 的技术和临床性能、PCR 检测的额外益处、未来的方面/考虑因素,以及如何在临床算法中最好地使用 PCR 来提供 PcP 的可能性。

专家意见

鉴于目前用于 PcP 的参考检测并不完美,替代方法将是有益的。对 PcP PCR 产生假阳性结果的担忧是合理的,但可以通过使用驱动特异性的阳性阈值来解决。不幸的是,广泛的 PCR 检测方法使提供 PCR 参考方法变得复杂。结合 PCR 和 B-D-葡聚糖以及临床和宿主危险因素的联合检测,是了解个人 PcP 可能性的关键。通过技术和后勤发展来改善 PcP PCR 检测的获取至关重要。相反,需要对包括 PcP 在内的综合征方法进行全面评估。

相似文献

1
Strengths and limitations of molecular diagnostics for pneumonia.肺炎分子诊断的优势与局限性。
Expert Rev Mol Diagn. 2024 Oct;24(10):899-911. doi: 10.1080/14737159.2024.2405920. Epub 2024 Nov 18.
2
Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.血清学诊断 HIV 感染者肺孢子菌肺炎:一项回顾性病例对照研究
BMC Infect Dis. 2019 Jul 23;19(1):658. doi: 10.1186/s12879-019-4289-4.
3
Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.肺孢子菌聚合酶链反应及血液(1→3)-β-D-葡聚糖检测对疑似耶氏肺孢子菌肺炎患者生存情况的预测价值
J Infect Chemother. 2014 Feb;20(2):109-14. doi: 10.1016/j.jiac.2013.09.004. Epub 2013 Dec 11.
4
Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.两种实时荧光定量聚合酶链反应检测方法在诊断人类免疫缺陷病毒(HIV)感染及非HIV免疫功能低下患者耶氏肺孢子菌肺炎中的比较
Diagn Microbiol Infect Dis. 2015 Jun;82(2):143-7. doi: 10.1016/j.diagmicrobio.2015.03.006. Epub 2015 Mar 12.
5
Recent Advances in the Diagnosis of Pneumocystis Pneumonia.肺孢子菌肺炎诊断的最新进展
Med Mycol J. 2016;57(4):E111-E116. doi: 10.3314/mmj.16-00019.
6
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.多中心、前瞻性临床评估应用商业实时 PCR 检测试剂盒检测肺孢子菌感染高危人群呼吸道样本。
J Clin Microbiol. 2011 May;49(5):1872-8. doi: 10.1128/JCM.02390-10. Epub 2011 Mar 2.
7
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.定量 PCR 诊断免疫功能低下非 HIV 患者肺孢子菌肺炎。
Eur Respir J. 2012 Apr;39(4):971-8. doi: 10.1183/09031936.00095811. Epub 2011 Sep 15.
8
Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.定量触底主要表面糖蛋白聚合酶链反应在诊断卡氏肺孢子虫肺炎中的特征和临床相关性。
Med Mycol. 2011 Oct;49(7):704-13. doi: 10.3109/13693786.2011.566894. Epub 2011 Mar 18.
9
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.联合检测肺部肺孢子菌 DNA 和血清(1->3)-β-D-葡聚糖对肺孢子菌肺炎和肺孢子菌定植的鉴别诊断。
J Clin Microbiol. 2013 Oct;51(10):3380-8. doi: 10.1128/JCM.01554-13. Epub 2013 Jul 31.
10
Ability of quantitative PCR to discriminate pneumonia from colonization.定量 PCR 区分肺炎与定植的能力。
J Med Microbiol. 2020 May;69(5):705-711. doi: 10.1099/jmm.0.001190. Epub 2020 Apr 28.

引用本文的文献

1
pneumonia in thoracic organ transplantation: Current perspectives and updates.胸器官移植中的肺炎:当前观点与进展
JHLT Open. 2025 Aug 7;10:100367. doi: 10.1016/j.jhlto.2025.100367. eCollection 2025 Nov.
2
Mortality of pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG.重症监护病房中肺炎的死亡率:欧洲危重症感染学会(ESGCIP)和欧洲重症监护学会(EFISG)一项国际多中心研究的事后分析
Ann Med. 2025 Dec;57(1):2511043. doi: 10.1080/07853890.2025.2511043. Epub 2025 Jun 14.